nintedanib

It is used to treat idiopathic pulmonary fibrosis (IPF) in adults, other chronic progressive fibrosing interstitial lung diseases (ILD) in adults, progressive fibrosing interstitial lung diseases in children and adolescents (from 6 years of age and older), and systemic sclerosis-associated interstitial lung disease (SSc-ILD) in adults and young people from 6 years of age and older. The medicine helps to reduce the appearance of further scarring and lung stiffness.

Form: capsules, soft gelatin

ATC: L01EX09

Manufacturer: ACCORD HEALTHCARE, S.L.U.

This medicine is used to treat idiopathic pulmonary fibrosis (IPF) in adults, other chronic fibrosing interstitial lung diseases (ILD) with a progressive phenotype, systemic sclerosis-associated interstitial lung disease (SSc-ILD) in adults, adolescents, and children from 6 years of age, and non-small cell lung cancer (NSCLC) in adults, in combination with docetaxel.

Form: capsules, soft gelatin

ATC: L01EX09

Manufacturer: DR. REDDY'S S.R.L.

This medicine is used in adults for the treatment of idiopathic pulmonary fibrosis (IPF), other chronic progressive fibrosing interstitial lung diseases (ILD), and interstitial lung disease associated with systemic sclerosis (SSc-ILD). It helps to reduce the appearance of new scarring and the stiffening of the lungs.

Form: capsules, soft gelatin

ATC: L01EX09

Manufacturer: SANDOZ S.P.A.

It is used to treat idiopathic pulmonary fibrosis (IPF) in adults, other chronic progressive fibrosing interstitial lung diseases (ILDs) in adults, fibrosing interstitial lung diseases in children and adolescents (6-17 years), and systemic sclerosis-associated interstitial lung disease (SSc-ILD) in adults and children/adolescents.

Form: capsules, soft gelatin

ATC: L01EX09

Manufacturer: VIATRIS LIMITED